Literature DB >> 26148460

[Skin disorders in malignant hematologic diseases].

M Schmid-Wendtner1, T Hornung, M Meurer, C-M Wendtner.   

Abstract

Numerous cutaneous manifestations have been reported in patients with hematologic malignancies. This review provides an overview on this subject by dividing skin lesions into three main groups: (1) skin disorders due to vascular changes (dilatation, occlusion and inflammation), (2) unspecific (e.g. paleness, opportunistic infections) and specific skin lesions (e.g. leukemia cutis), and (3) the large group of paraneoplastic skin disorders. Emphasis is placed on clinical findings and therapeutic options of those paraneoplastic syndromes that are most frequently found in hematologic malignancies.

Entities:  

Mesh：

Year:  2015        PMID： 26148460     DOI： 10.1007/s00105-015-3650-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  20 in total

Review 1.  Research in practice: substance P antagonism in chronic pruritus.

Authors:  Tobias Lotts; Sonja Ständer
Journal:  J Dtsch Dermatol Ges       Date:  2014-05-24       Impact factor: 5.584

2.  Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study.

Authors:  S A Johannesdottir; D K Farkas; G R Vinding; L Pedersen; A Lamberg; H T Sørensen; A B Olesen
Journal:  Br J Dermatol       Date:  2014-09-28       Impact factor: 9.302

Review 3.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

4.  [Autoinflammatory syndromes/fever syndromes].

Authors:  J Schedel; B Bach; J B Kümmerle-Deschner; I Kötter
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

Review 5.  Cancer and thromboembolic disease: pathogenic mechanisms.

Authors:  Agnes Y Lee
Journal:  Cancer Treat Rev       Date:  2002-06       Impact factor: 12.111

6.  Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.

Authors:  Filiberto Cedeno-Laurent; Elisha M Singer; Maria Wysocka; Bernice M Benoit; Carmela C Vittorio; Ellen J Kim; Gil Yosipovitch; Alain H Rook
Journal:  Clin Immunol       Date:  2015-03-08       Impact factor: 3.969

7.  Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

Authors:  P Prandoni; A W Lensing; H R Büller; A Cogo; M H Prins; A M Cattelan; S Cuppini; F Noventa; J W ten Cate
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

Review 8.  Cutaneous vascular disorders associated with internal malignancy.

Authors:  Abdel Kader El Tal; Zeina Tannous
Journal:  Dermatol Clin       Date:  2008-01       Impact factor: 3.478

9.  Sweet's syndrome: systemic signs and symptoms and associated disorders.

Authors:  D L Fett; L E Gibson; W P Su
Journal:  Mayo Clin Proc       Date:  1995-03       Impact factor: 7.616

10.  [Sweet syndrome in chronic myeloid leukemia].

Authors:  G Rauh; U Gresser; M Meurer; H Dörfler
Journal:  Klin Wochenschr       Date:  1989-05-02
View more
  2 in total

Review 1.  Immune-Mediated Cutaneous Paraneoplastic Syndromes Associated With Hematologic Malignancies: Skin as a Mirror of Hematologic Neoplasms.

Authors:  Jose C Alvarez-Payares; Angel Molina; Simon Gallo; Julian Ramirez; Juan Hernandez; Fernando Lopez; Sara I Ramirez-Urrea; Cristian Álvarez
Journal:  Cureus       Date:  2021-11-13

Review 2.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.